Roadmaps to the Intertwined IP and Regulatory Regimes in China

May 13, 2020 9:00 AM to 10:00 AM

Location

Virtual - all times are eastern daylight time

Credits

60 Minutes of MCLE

Moderator: Jeremy K. McKown, Janssen R&D, New Brunswick, NJ

Topics

Developments in pharmaceutical IP and regulatory coordination efforts to stimulate faster and better pharmaceutical development in China
Juhua Luo, CCPIT Patent and Trademark Law Office, Beijing, China 

Using Patent Law and Policy for Incentivizing Green Technology Innovation in China

Wen Cao, Principal of Shanghai Office of NTD, Shanghai, China

Presented by the IP Practice in China Committee and the US Group of AIPPI

Speakers

  • Luo Photo Luo, Juhua

    CCPIT Patent and Trademark Law Office

    Mr. Luo's practice focuses mainly on prosecution of patent.
  • McKown, Jeremy square200 McKown, Jeremy K.

    Johnson & Johnson | Global Patent Head

    Jeremy is the Global Patent Head of Johnson & Johnson’s pharmaceutical business, where he manages a global team of attorneys and professionals focused on creating robust patent portfolios and providing strategic counsel to its’ Innovative Medicine companies. In addition, he advises on material R&D transactions and IP litigations, and actively works with external trade associations to ensure we have meaningful IP policies. Previously, he led the R&D Legal team responsible for drafting and negotiating complex agreements for J&J’s Innovative Medicine companies.
  • Cao Photo Cao, Wen

    Shanghai Office of NTD | Senior Partner

    Ms. Cao serves as the principal of NTD Shanghai Office.